Investigational Site Number 840202 — Wyomissing, Pennsylvania

Investigational Site Number 840202 is a clinical research site located in Wyomissing, Pennsylvania, United States 19610.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840202 has participated in 1 clinical trials.

Therapeutic areas: Hypercholesterolemia.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wyomissing

Browse all research sites in Pennsylvania · View every site in Wyomissing

• reading Hospital /ID# 223599
• Reading Hospital Study
• Reading Hospital/McGlinn Cancer Institute
• Clinical Research Center of Reading
• Research Site
• GSK Investigational Site
• Pfizer Investigational Site
• Berks Cardiologists, LTD
• Radiant Research
• Respiratory Specialists
• Clinical Research Center of Reading LLP
• Digestive Disease Associates

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840202?

Investigational Site Number 840202 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840202 conducted?

Investigational Site Number 840202 has 1 clinical trials on record. Their work covers Hypercholesterolemia.

Is Investigational Site Number 840202 accredited by Crixeo Clinical Trials?

Investigational Site Number 840202 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840202?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.